Key Dates

Related Announcements

NOT-EB-22-001 - Notice of Intent to Publish a Funding Opportunity Announcement for Point-of-Care Technologies Research Network Centers (U54 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The National Institute on Drug Abuse (NIDA) is participating in NOT-EB-22-001 - Notice of Intent to Publish a Funding Opportunity Announcement for Point-of-Care Technologies Research Network (POCTRN) Centers (U54 Clinical Trial Optional).

NIDA seeks applications to promote the transition of scientific discoveries and engineering advances into tools or devices that improve: 1) drug detection, drug screening, and drug quantification with the goal of diagnosis, treatment, treatment monitoring and/or disease management; 2) determination of cause of death in cases of suspected drug overdose.

NIDA is planning to fund one Center for the development, validation and/or adoption of point-of -need (PON) technologies in clinical and other settings where they will be deployed. The NIDA POCTRN center is expected to facilitate the development of PON technologies for the substance use disorder (SUD) care continuum, including technologies to address challenges and barriers associated with SUD health disparities and low resource settings. For this purpose, the center will be expected to engage underserved minorities, tribes, as well as justice system-involved groups during technology optimization and validation.

Examples of PON technologies of interest to NIDA could include, but are not limited to:

• Technologies for drug quantification in blood, saliva, sweat or tissues, with minimal or no sample preparation;
• Technologies capable of analyzing 2 or more matrices without change in workflow;
• Reusable PON drug panels for rapid toxicology testing;
• Low-cost electrochemical, optical or calorimetric-based PON platforms for drug detection;
• Technologies focused on rapid detection of emerging drugs of abuse and drug analogs;
• Technologies that enable processing of complex samples in PON settings to facilitate the use of existing technologies

Inquiries

Please direct all inquiries to:

Dr. Yordan Kostov
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-5650
Email: yordan.kostov@nih.gov